Sanaria has won a three-year, $3 million phase 2 Small Business Research Innovation grant from the National Institutes of Health to further develop its malaria vaccine. The money will support research by scientists at the Rockville company and its partner, Columbia University, according to Sanaria information. The new grant continues earlier NIH-supported efforts at Sanaria and Columbia to … [Read more...]